Natural killer cells

Natural killer cells are often metaphorised as the secret police of the immune system, implying that immunity is a fascist state organ that effects a repressive control over cell function through intimidation and extrajudicial violence. The delightful extension of this is that it forces the reader to take one of two equally insane ideological positions, where they would either view malignant and virus-infected cells as revolutionaries or resistance fighters, or by denouncing them as terrorists and radical insurgents, to side with fascism. This breed of small granular lymphocyte pre-dates the evolutionary advent of more sophisticated and complex T cell control systems, but performs a similar role of identifying and eliminating abnormal cells of the host (similarly to cytotoxic T-cells and in contrast to the civic business of other leukocytes which mostly focus on the elimination of foreign cells and their products). Their name was crafted by Kiessling et al (1975) on the basis of the fact that these cells were "naturally occurring" in the spleen of their mice and appeared to recognise and destroy injected leukaemia cells without hesitation, as opposed to T lymphocytes which needed to be trained to recognise them first ( T lymphocytes being at this stage colloquially referred to as "killer cells" because of their direct cytotoxic activity).  "A simple explanation would be that they are directed against murine leukemia virus antigens, ... as such viruses are known to be quite ubiquitous", the authors speculated. Indeed these cells respond to characteristic biomarkers which are available without prior exposure, and are therefore grouped along with neutrophils and macrophages as a part of the innate immune system. 

In summary:

  • Natural killer cell structure
    • Size: 7-9 μm, small for a leukocyte but large for a lymphocyte
    • Nucleus: Solitary and round nucleus
    • Granules: small azurophilic granules with peforin and grqanzyme
    • Microscopy: Indistingushable from other lymphocytes, and in fact biochemically just T-cells without TCR receptor complexes.
  • Natural killer cell distribution and fate
    • Released from bone marrow; circulate for a short time;
    • Reside in tissues (thymus, spleen, liver)
    • Half life is ~ 10 days
    • Can reproduce outside the bone marrow
  • Natural killer cell functions
    • Tumour and virus surveillance: recognition of abnormal cells by their failure to express normal markers, such as MHC I
    • Cytolysis: binding to targeted cells via a "immune synapse" surface, and then using perforins to introduce proapoptotic signalling molecules
    • Regulatory function: Secrete cytokines, especially IFN-γ
  • Natural killer cell testing
    • Difficult to identify under normal circumstances (eg. using the CD56 receptor)
    • Very few genuine indications for this sort of testing in the critical care environment
  • Drugs that inhibit natural killer cell activity
    • Stimulatory agents: thalidomide, lenalidomide, or pomalidomide; azacytidine and decitabine; and especially interferon
    • Suppressive agents: corticosteroids (most potent),  mycophenolate, sirolimus and everolimus, imatinib dasatinib and nilotinib, sodium valproate, bortezomib

This chapter has zero relevance to any specific element of Section S  from the 2023 CICM Primary Syllabus, and natural killer cells are highly unlikely to become the subject of a basic science or data interpretation question, making this exact sentence an excellent inflection point where most readers can safely turn around. Farag & Caligiuri (2006) or just Caligiuri (2008) would be reasonable references for anyone who needs to know more for whatever reason.

Structure of natural killer cells

NK cells were not discovered until the mid-1970s mostly because their structure is indistinguishable from T cells, and modern biologists generally define them phenotypically by the presence of CD56  on their surface. The normal full blood count does not report these as a separate species because the automated cell counter in your local pathology lab probably uses a 5-part differential analyser based on the Coulter principle and laser flow cytometry, neither of which would detect the difference between B cells, T cells and NK cells. On average they are large for a lymphocyte (7-9 μm), which is small for a leukocyte generally, with a large nucleus containing coarse chromatin, and basophilic cytoplasm granules. Upon contact with a target, they develop a large surface area which is facilitated by the presence of microvilli, but this is not revealed by light microscopy. Though the lineage is generally referred to by the generic "NK cell" label, there are in fact a myriad of different phenotypes with different patterns of activity and tissue distribution. 

Distribution and life cycle of natural killer cells

That these cells so closely resemble other lymphocytes is not accidental. It appears that a proportion of them arise from secondary lymphoid tissues such as the spleen and tonsils, but most arise in the bone marrow from the same progenitor as T-lymphocytes, and are mostly just T cells without a TCR receptor.  Blum & Pabst (2007) counted only about 2 billion of these in the bloodstream, where they circulate for only hours. Their tissue distribution is mostly in the spleen thymus and liver, and they are mostly absent from the lymph nodes and the lung. The lifespan of NK cells is said to be short by lymphocyte standards - a half-life of 10 days is quoted by Nayar et al (2015), with a dependence on IL-15 as a surivial promoter cytokine. They are therefore a dynamic pool, and various sources suggest that at the end they disappear into the liver and spleen as all senescent cells are generally expected to. 

Function of natural killer cells

The function of NK cells which has brought about their comparison to the Gestapo is their ability to detect and react to cell surface markers of host cells, whereas other immune cells typically react to the sell surface markers of foreign cells. NK cells are therefore able to observe for abnormal host cells, and then to perform various lethal and nonlethal effector functions. Thus:

Tumour immunosurveillance- NK cells rely on the fact that tumour cells are, at a fundamental level, undisciplined and slack. The result of this lassitude is their tendency to forget to express self-identifying receptor ligands such as, for example, the MHC class I molecule that is supposed to be on the surface of all vertebrate cells. Ergo, the absence of these key surface features is interpreted as abnormality, and the cell is targeted for destruction. Well, the situation is clearly more complex than that, but this is the basic gist.

Virus immunosurveillance: cells infected by viruses may also underexpress MHC I molecules, which is an adaptive viral response to T-cell mediated immunity.  The "missing self hypothesis" suggests that originally the invention of NK cells was a reaction by the vertebrates to the classic virus and tumour parlour trick, where the disease cells fail to express MHC I molecules and therefore become invisible to T cells (which rely on antigen presentation by MHC I to recognise virus-infected cells). Ergo, to overcome this, a clone of lymphocytes that detected this trickery was needed, and this is credited with the development of  NK cells. They notice when the receptor is missing. This is somewhat odd, as all animals are affected by viruses, whereas like all lymphocyte lineages NK cells are generally considered the innovation of vertebrates. However  Khalturin et al (2004 and 2003) contend that NK-like activity is seen in the cells of even "lower" beasts such as the tunicate Botryllus schlosseri, and those do not have any lymphocytes from which to differentiate, so perhaps some cellular viral defence tactics have evolved independently. 

Surveillance for senescent cells:  cells that express the ligands for NKG2D and DNAM-1 NK cell surface receptors identify themselves as sick, stressed, or dying; and are promptly destroyed by NK cells (Antonangeli et al, 2019). Which brings us to the question, destroyed exactly how?

Cytotoxic functions of NK cells: The small azurophilic granules in their membranes are full of perforin and granzyme proteases, which are used together to induce apoptosis. NK cells appear to bind to the surface of their target and create a high-surface-area bond described in the literature as an "immunological synapse", where perforins are used to perforate the target membrane so that death receptor ligands (FasL, TNF and TRAIL) can be introduced directly into it, stimulating apoptosis. That apoptosis is coordinated instead of lysis is important because the objective is often to contain the spill of virus particles in a controlled implosion of the diseased host cell. 

Regulatory functions of NK cells: These cells are credited with the production of interferon gamma (IFN-γ) which is a counterproliferative signal and an all-round bugle call to the immune system; but they also secrete TNF-α, GM-CSF, IL-10, IL-5, and IL-13, and so can be described as having a regulatory function.

Causes of increased and decreased NK cell numbers 

NK cells are not really seen outside of specific targeted cytology studies and are therefore unlikely to appear as a randomly elevated unexplained count in the blood results of an ICU patient. Nor would the intensivist usually know how to interpret such a count, nor is there any literature to guide them. In fact, there is usually no reason to order a specific NK cell count, outside of haematological malignancy. That is not to as that they are unimportant - Orange (2006) lists many examples of rapidly fatal congenital deficiencies - but these are so rare, and the peripheral concentration of these cells so unrelated to their activity and function, that the difficult process of measuring them seems rather pointless.

Drugs that influence NK cell activity

Even though a search for drugs that do something to NK cells does tend to turn up some literature, "future directions" or "future perspectives" is how the article titles tend to end, to indicate a certain wishful fantasy-like quality for their applications. From Krieg & Ullrich (2013):

  • Agents that stimulate various facets of NK cell function include:
    • thalidomide, lenalidomide, or pomalidomide increase NK cell activity
    • azacytidine and decitabine sensitize tumour cells to NK-cell-mediated apoptotic "killing"
    • Interferon (activates all of their functions)
  • Agents that suppress NK cells:
    • Imatinib dasatinib and nilotinib all do different things (some inhibit and some enhance cytotoxicity)
    • Sodium valproate inhibits cytokine production by NK cells
    • Bortezomib has a pro-apoptotic effect on resting NK cells
    • When Qin et al (2023) explored the influence of different immunosuppressants on NK cells, they found that:
      • Corticosteroids were the most potent NK suppressors
      • Mycophenolate was the next most potent
      • Sirolimus and everolimus were the least potent

References

Caligiuri, Michael A. "Human natural killer cells." Blood, The Journal of the American Society of Hematology 112.3 (2008): 461-469.

Lanier, Lewis L. "Five decades of natural killer cell discovery." Journal of Experimental Medicine 221.8 (2024): e20231222.

Kiessling, Rolf, Eva Klein, and H. Wigzell. "„Natural” ︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype." European journal of immunology 5.2 (1975): 112-117.

Ng, W., et al. "Ultrastructure of cytokine induced human natural killer cells." Cytotherapy 21.5 (2019): S52-S53.

Vivier, Eric, et al. "Functions of natural killer cells." Nature immunology 9.5 (2008): 503-510.

Farag, Sherif S., and Michael A. Caligiuri. "Human natural killer cell development and biology." Blood reviews 20.3 (2006): 123-137.

Cooper, Megan A., and Michael A. Caligiuri. "Isolation and characterization of human natural killer cell subsets." Current Protocols in Immunology 60.1 (2004): 7-34.

Gayathri, R., and T. Harini. "CBC 5 Part Analyser." (2018).

Kumar, Amrendra, et al. "Natural killer T cells: an ecological evolutionary developmental biology perspective." Frontiers in immunology 8 (2017): 1858.

Khalturin, Konstantin, et al. "Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus." Proceedings of the National Academy of Sciences 100.2 (2003): 622-627.

Cooper, Max D., and Matthew N. Alder. "The evolution of adaptive immune systems." Cell 124.4 (2006): 815-822.

Antonangeli, Fabrizio, et al. "Senescent cells: Living or dying is a matter of NK cells." Journal of leukocyte biology 105.6 (2019): 1275-1283.

Iannello, Alexandre, and David H. Raulet. "Immune surveillance of unhealthy cells by natural killer cells." Cold Spring Harbor symposia on quantitative biology. Vol. 78. Cold Spring Harbor Laboratory Press, 2013.

Perera Molligoda Arachchige, Arosh Shavinda. "Human NK cells: From development to effector functions." Innate immunity 27.3 (2021): 212-229.

Roitt, Ivan M., et al. "The cellular basis of immunological responses: a synthesis of some current views." The Lancet 294.7616 (1969): 367-371.

Boehm, Thomas. "Evolution of vertebrate immunity." Current Biology 22.17 (2012): R722-R732.

Khalturin, Konstantin, et al. "Recognition strategies in the innate immune system of ancestral chordates." Molecular immunology 41.11 (2004): 1077-1087.

Blum, Katrin S., and Reinhard Pabst. "Lymphocyte numbers and subsets in the human blood: do they mirror the situation in all organs?." Immunology letters 108.1 (2007): 45-51.

Nayar, Sandeep, Prokar Dasgupta, and Christine Galustian. "Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review." Oncoimmunology 4.4 (2015): e1002720.

Letafati, Arash, et al. "Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications." Virology Journal 21.1 (2024): 18.

Herberman, Ronald, ed. Mechanisms of cytotoxicity by NK cells. Elsevier, 2012.

Orange, Jordan S. "Human natural killer cell deficiencies." Current opinion in allergy and clinical immunology 6.6 (2006): 399-409.

Campbell, Kerry S., and Jun Hasegawa. "Natural killer cell biology: an update and future directions." Journal of Allergy and Clinical Immunology 132.3 (2013): 536-544.

Krieg, Stephanie, and Evelyn Ullrich. "Novel immune modulators used in hematology: impact on NK cells." Frontiers in immunology 3 (2013): 388.

Qin, Rongrong, et al. "Influence of immunosuppressive drugs on natural killer cells in therapeutic drug exposure in liver transplantation." Hepatobiliary Surgery and Nutrition 12.6 (2023): 835.